MedPath

Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients

Phase 4
Conditions
Protein-Energy Malnutrition
Hemodialysis
Kidney Failure, Chronic
Interventions
Dietary Supplement: Egg albumin-based protein supplement
Dietary Supplement: Renal-specific oral supplement
Registration Number
NCT01981083
Lead Sponsor
Centro Medico Lic Adolfo Lopez Mate
Brief Summary

Malnutrition is seen frequently in hemodialysis units in most developing countries. Malnutrition increases morbidity and mortality in this population and its treatment improves patient survival and health status The purpose of this study is to compare two strategies to improve nutritional status in hemodialysis patients: renal-specific oral supplement (237 ml) versus egg albumin-based protein supplement (30 g) on a daily basis.

This trial uses the Malnutrition Inflammation Score (MIS) and Subjective Global Assessment (SGA) in addition to most used biochemical markers to determine nutritional status.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Chronic Kidney Disease in Hemodialysis
Exclusion Criteria
  • Infection
  • Liver insufficiency
  • Cancer or neoplasia
  • Acquired immunodeficiency syndrome
  • Intestinal malabsorption syndrome

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Egg albumin-based protein supplementEgg albumin-based protein supplementPowder form, dosage 30 g daily, duration 6 months
Renal-specific oral supplementRenal-specific oral supplementLiquid form, dosage 237 ml (one can) daily, duration 6 months
Primary Outcome Measures
NameTimeMethod
Change in Malnutrition-Inflammation ScoreBimonthly, up to six months
Change in Subjective Global AssessmentBimonthly, up to six months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centro Medico Lic. Adolfo López Mateos

🇲🇽

Toluca, Estado de Mexico, Mexico

© Copyright 2025. All Rights Reserved by MedPath